Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.07 is 36% above its 5-year average of 2.26, near the low end of its 5-year range (0.82–15.07).
As of the fiscal period ended Tuesday, June 30, 2026. 72.00% above its 12-month average of 1.78.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.07.
QUICK RATIO (ACID-TEST)
3.07
QUICK RATIO (ACID-TEST) AVG TTM
1.78
QUICK RATIO (ACID-TEST) AVG 3Y
1.33
QUICK RATIO (ACID-TEST) AVG 5Y
2.26
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+72.00%
CURRENT VS 3Y AVG
+129.82%
CURRENT VS 5Y AVG
+35.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
+2.55%
vs the sector median at left
Market Cap
$49.21M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.22
3Y Avg
0.27
5Y Avg
0.92
Market Cap
$51.17M
Quick Ratio (Acid-Test)
0.96
TTM Avg
1.17
3Y Avg
2.45
5Y Avg
4.99
Market Cap
$51.23M
Quick Ratio (Acid-Test)
3.81
TTM Avg
5.31
3Y Avg
3.36
5Y Avg
3.21
Market Cap
$51.84M
Quick Ratio (Acid-Test)
4.04
TTM Avg
3.34
3Y Avg
3.69
5Y Avg
8.08
Market Cap
$51.72M
Quick Ratio (Acid-Test)
1.61
TTM Avg
0.71
3Y Avg
0.60
5Y Avg
0.61
Market Cap
$47.64M
Quick Ratio (Acid-Test)
5.74
TTM Avg
9.62
3Y Avg
7.35
5Y Avg
7.40
Market Cap
$46.88M
Quick Ratio (Acid-Test)
0.76
TTM Avg
2.59
3Y Avg
1.53
5Y Avg
1.04
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $49.84M | 3.07 | 1.78 | 1.33 | 2.26 |
| biote Corp. (BTMD)vs › | $49.40M | 0.82 | 0.91 | 2.84 | 2.59 |
| Celularity Inc. (CELU)vs › | $49.21M | 0.08 | 0.22 | 0.27 | 0.92 |
| Apollomics, Inc. (APLM)vs › | $51.17M | 0.96 | 1.17 | 2.45 | 4.99 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 3.81 | 5.31 | 3.36 | 3.21 |
| INmune Bio, Inc. (INMB)vs › | $51.84M | 4.04 | 3.34 | 3.69 | 8.08 |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | 1.61 | 0.71 | 0.60 | 0.61 |
| Lite Strategy, Inc. (LITS)vs › | $47.64M | 5.74 | 9.62 | 7.35 | 7.40 |
| BioStem Technologies, Inc. (BSEM)vs › | $46.88M | 0.76 | 2.59 | 1.53 | 1.04 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | 3.89 | 3.98 | 6.90 | 10.09 |
Quick Ratio
3.07
Excludes inventory
Current Ratio
3.07
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.07 |
| 2026-03-31 | 1.93 |
| 2025-12-31 | 0.83 |
| 2025-09-30 | 1.52 |
| 2025-06-30 | 1.57 |
| 2025-03-31 | 1.36 |
| 2024-12-31 | 1.56 |
| 2024-09-30 | 0.82 |
| 2024-06-30 | 0.99 |
| 2024-03-31 | 1.22 |
| 2023-12-31 | 1.53 |
| 2023-09-30 | 3.04 |
| 2023-06-30 | 9.30 |
| 2023-03-31 | 1.47 |
| 2022-12-31 | 2.10 |
| 2022-09-30 | 3.49 |
| 2022-06-30 | 4.11 |
| 2022-03-31 | 7.76 |
| 2021-12-31 | 9.05 |
| 2021-09-30 | 13.53 |
| 2021-06-30 | 15.07 |
| 2021-03-31 | 12.97 |
| 2020-12-31 | 5.38 |
| 2020-09-30 | 6.91 |
| 2020-06-30 | 0.88 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.19 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
